Alliance Pharmaceutical Corp.

Alliance Pharmaceutical Corp. is a research and development company focused on transforming innovative scientific discoveries into novel therapeutic and diagnostic agents. Alliance Pharmaceutical Corp is a pharmaceutical research and development company that focuses on developing scientific discoveries into medical products and licensing these products to multinational pharmaceutical companies in exchange for fixed payments and royalties. To date, the Company has developed three innovative products through initial clinical (human) trials, and is in, or is preparing to enter, pivotal clinical trials for these products. The products are OXYGENT-TM-, an intravascular oxygen carrier to temporarily augment oxygen delivery in surgical and other patients at risk of acute tissue hypoxia (oxygen deficiency); LIQUIVENT-Registered Trademark-, an intrapulmonary agent for use in reducing a patient's exposure to the harmful effects of conventional mechanical ventilation; and IMAGENT-Registered Trademark-, an intravenous contrast agent for enhancement of ultrasound images to assess cardic function, organ lesions and to detect blood flow abnormalities, which is licensed to Schering AG, Germany.

Activity:

- Licensing & Business Development
- Research & Development

Product / Technology type(s) covered:

- Diagnostics
- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: